+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Markets for Vaccine Technologies

  • ID: 5139318
  • Report
  • August 2020
  • Region: Global
  • 200 Pages
  • BCC Research

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Manguinhos
  • Elanco Animal Health
  • Ibio Inc.
  • Novartis Pharma Ag
  • Sanofi Pasteur

Report Scope:

The report explains critical trends in the vaccine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakeholders and potential entrants.

Broadly speaking, depending on whether they prevent diseases or treat pre-existing ones, vaccines can be divided into prophylactic and therapeutic vaccines. In contrast, animal vaccines are categorized by food-producing animals (porcine, bovine, poultry, ovine, fish) and companion animals (canine, feline and equine vaccines), as well as vaccines for other animal species.

This study looks at most of the systems affected by factors such as considerable research and development (R&D) spending and increasing competition and new technologies, which are giving direction to the market. These advancements, new product launches, and changing lifestyles are influencing the future market growth.

Company merger acquisition strategies and collaborations are also covered in this report. Additionally, this study discusses the strengths and weaknesses of each strategy type considering new technologies, growing competition, and changing customer needs.

The market has also been analyzed based on the application of current vaccines. Categories considered in this report include meningococcal/pneumococcal vaccines, influenza vaccines, pediatric polio/pertussis/Hib vaccines, adult/adolescent booster vaccines, vaccines for travel-related and other endemic diseases, HPV vaccines, rotavirus vaccines, and other (minor) vaccines.

This study details market growth among vaccine manufacturers and end-users. Genomic research centers, academic institutions, government and private laboratories, and various hospital settings, as well as pharmaceutical, diagnostic, and biotechnology companies and physicians, will find this study to be of interest.

The report provides useful information to all market players, potential entrants, government agencies, and other interested parties. As the report covers geographic regions in detail, companies interested in expanding their geographic reach will also find this study useful.

The Report Includes:

  • 34 data tables and 54 additional tables
  • A descriptive overview of the global markets for vaccine technologies and their applications
  • Analyses of the global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Evaluation of the current market size, market estimation and forecast, pipeline analysis of new products; and discussion of opportunities, drivers and challenges affecting the overall marketplace
  • The brief general outlook of the recent market developments, technological advancements, government regulations and policies, patent analyses and upcoming technologies, R&D activities related to the vaccine technology industry
  • Identification of present and future strategies within the vaccine technology market and examination of vaccines for both humans and animals
  • Opportunities and highlights of this innovation-driven vaccine technologies market, and the major regions and countries involved in market developments and their immunization schedule
  • A separate chapter on COVID-19 pandemic impact on the present and future vaccines market, major COVID-19 vaccine candidates under development, and impact of the outbreak on vaccine supplies
  • Detailed company profiles of the market-leading participants, including Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bayer Animal Health, GlaxoSmithKline (GSK), Merck & Co. Inc., Johnson & Johnson Inc., Novartis, Pfizer, Sanofi Pasteur, and Thermo Fisher Scientific
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Manguinhos
  • Elanco Animal Health
  • Ibio Inc.
  • Novartis Pharma Ag
  • Sanofi Pasteur

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology
  • Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Definitions
  • Immune System and Vaccines
  • How Vaccines Work?
  • Types of Immunity
  • Advantages of Vaccination
  • History of Vaccines
  • Types of Vaccines
  • Attenuated (Live) Vaccines
  • Inactivated (Killed) Vaccines
  • Toxoid Vaccines
  • Subunit Vaccines
  • Conjugate Vaccines
  • Recombinant Vector Vaccines
  • DNA Vaccines
  • RNA Vaccines
  • Adjuvants and Excipients
  • Pathogen Components
  • Particulate Adjuvants
  • Infectious Diseases Preventable by Vaccines
  • Human Diseases
  • Viral Diseases
  • Bacterial Diseases
  • Animal Diseases
  • Food-Producing Animals
  • Companion Animals
  • Other Animals
  • Rapid Manufacturing for Pandemics
  • Types of Vaccine Manufacturing Methods
  • Plant-Based Vaccines
  • Egg-Based Vaccine Manufacturing
  • Cell-Based Vaccines
  • Investigational Vaccine Manufacturing Methods
  • Clinical Development of Vaccines
  • Clinical Development of Pandemic Vaccines
  • Laws and Regulations
  • Vaccine Distribution in the Case of Pandemic Diseases
  • Government Initiatives
  • Recent Technologies and Companies
  • Technological Advancements Such as Rapid Manufacturing
  • Rising Immunization across the Globe
  • Government Support for Vaccine Development
  • Lack of Awareness in Low-Income Countries
  • Opportunities
  • RNA Vaccination
  • Rise of Antibiotic Resistance
  • Current Situation
  • Dynamics of the Market for Human Vaccines
  • Dynamics of the Market for Animal Vaccines
  • Regulatory Aspects
  • World Health Organization (WHO) Prequalified Vaccines
  • New Product Approvals
  • Recalls
  • Vaccine Shortage
  • Significant Regulatory Developments in Vaccine-Preventable Disease Products

Chapter 4 Market Breakdown by Human Vaccine

  • Human Vaccines by Type
  • Attenuated (Live) Vaccines
  • Inactivated Vaccines
  • Conjugate Vaccines
  • DNA/rDNA Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • Other/Combination Vaccines
  • Vaccines by Age Group
  • Pediatric Vaccines
  • Vaccines for Adolescents and Adults
  • Vaccines for the Geriatric Population
  • Vaccine by Disease Type
  • Diptheria
  • Influenza
  • Hepatitis A
  • Measles
  • Rotavirus
  • Chickenpox
  • Other Diseases and Combination Vaccines
  • Outbreak of Diseases
  • Vaccines by Delivery Route
  • Intramuscular Injection
  • Intradermal Injection
  • Mucosal Vaccination
  • Nanopatch

Chapter 5 Market Breakdown by Animal Vaccine

  • Animal Vaccines
  • Market by Type

Chapter 6 Market Breakdown by Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Rest of APAC
  • Rest of the World

Chapter 7 COVID-19 Impact on Present and Future

  • Impact of COVID-19 on Vaccine Supplies
  • Massive Impact on Lower-Income Countries Threatens More Disease Outbreaks

Chapter 8 Company Profiles

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Astrazeneca Plc
  • Baxter International Inc.
  • Bayer Animal Health
  • Bharat Biotech International Ltd.
  • Biological E. Ltd.
  • Bio-Manguinhos
  • Bioproperties Pty Ltd.
  • Boehringer Ingelheim Gmbh
  • Bul Bio National Center Of Infectious And Parasitic Diseases Ltd. (Bb-Ncipd Ltd.)
  • Cadila Healthcare Ltd. (Zydus Cadila)
  • Ceva Sante Animale
  • China National Biotec Group (Cnbg)
  • Colorado Serum Co.
  • CSL Ltd.
  • Elanco Animal Health
  • Emergent Biosolutions Inc.
  • Fatro Spavia
  • GE Healthcare
  • Geneone Life Sciences Inc.
  • Precigen Inc. (Formerly Intrexon)
  • Geovax
  • Glaxosmithkline Plc
  • Green Cross Corp.
  • Ibio Inc.
  • Institut Pasteur De Dakar
  • Johnson & Johnson Inc.
  • LG Life Sciences
  • Maxcyte Inc.
  • Merck & Co., Inc.
  • Novartis Pharma Ag
  • Panacea Biotec Ltd.
  • Pfenex Inc.
  • Pfizer Inc.
  • Profectus Biosciences Inc.
  • PT Bio Farma
  • Replikins Ltd.
  • Sanofi Pasteur
  • Serum Institute Of India Ltd.
  • Statens Serum Institut
  • Thermo Fisher Scientific
  • Valneva Se
  • Virbac
  • Zoetis Inc.

List of Tables
Summary Table: Global Market for Vaccine Technologies, by Segment, Through 2025
Table 1: History of Vaccines, by Year
Table 2: Types of Attenuated (Live) Vaccines, by Segment
Table 3: Advantages and Disadvantages of Attenuated (Live) Vaccines
Table 4: Types of Inactivated (Killed) Vaccines, by Segment
Table 5: Advantages and Disadvantages of Inactivated (Killed) Vaccines
Table 6: Types of Toxoid Vaccines, by Segment
Table 7: Advantages and Disadvantages of Toxoid Vaccines
Table 8: Types of Subunit Vaccines, by Segment
Table 9: Advantages and Disadvantages of Subunit Vaccines
Table 10: Types of Conjugate Vaccines, by Segment
Table 11: Advantages and Disadvantages of Conjugate Vaccines
Table 12: Types of Recombinant Vector Vaccines, by Segment
Table 13: Advantages and Disadvantages of Recombinant Vector Vaccines
Table 14: Types of DNA Vaccines, by Segment
Table 15: Advantages and Disadvantages of DNA Vaccines
Table 16: Advantages and Disadvantages of RNA Vaccines
Table 17: Vaccine Excipient and Media Summary, Excipients included in U.S. Vaccines
Table 18: Vaccine-Preventable Human Viral Diseases
Table 19: Vaccine-Preventable Human Bacterial Diseases
Table 20: Vaccine-Preventable Parasitic Animal Diseases Found in Food-Producing Animals
Table 21: Vaccine-Preventable Bacterial Animal Diseases Found in Food-Producing Animals
Table 22: Vaccine-Preventable Viral Animal Diseases Found in Food-Producing Animals
Table 23: Vaccine-Preventable Parasitic Animal Diseases Found in Companion Animals
Table 24: Vaccine-Preventable Bacterial Animal Diseases Found in Companion Animals
Table 25: Vaccine-Preventable Viral Animal Diseases Found in Companion Animals
Table 26: Vaccine-Preventable Viral Animal Diseases Found in Other Animals
Table 27: Vaccine-Preventable Viral Animal for Food-Producing in Companion
Table 28: Cases of Diphtheria, by Country, 2011-2015
Table 29: Petitions Filed, Compensated and Dismissed about Vaccinessince the Beginning of VICP, 1998-2020
Table 30: WHO Prequalified Vaccines, January 2014-April 2020
Table 31: Newly Approved Vaccines, January 2014-April 2020
Table 32: Global Vaccine Recalls, by Manufacturer, January 2014-November 2017
Table 33: Global Vaccine Shortage, by Manufacturer, January 2012-November 2017
Table 34: Global Market for Human Vaccines, by Type, Through 2025
Table 35: Global Market for Attenuated (Live) Vaccines, by Region, Through 2025
Table 36: Global Market for Inactivated (Killed) Vaccines, by Region, Through 2025
Table 37: Global Market for Conjugate Vaccines, by Region, Through 2025
Table 38: Global Market for Recombinant/rDNA/DNA Vaccines, by Region, Through 2025
Table 39: Global Market for Subunit Vaccines, by Region,Through 2025
Table 40: Global Market for Toxoid Vaccines, by Region, Through 2025
Table 41: Global Market for Other/Combination Vaccines, by Region, Through 2025
Table 42: Global Market for Human Vaccines, by Age Group, Through 2025
Table 43: Pediatric Vaccines Doses
Table 44: Pediatric/VFC Vaccine Price List, 2019
Table 45: Influenza Vaccine Price List, 2020
Table 46: Pediatric Vaccines Doses, by Age Group
Table 47: Global Market for Human Vaccines for Pediatrics, by Region, Through 2025
Table 48: Global Market for Human Vaccines for Adults, by Region, Through 2025
Table 49: Adult Vaccine Price List
Table 50: Vaccine Price List for Geriatric Population
Table 51: Global Market for Human Vaccines for Geriatrics, by Region, Through 2025
Table 52: Vaccines, by Disease Type
Table 53: Global Market for Human Vaccines, by Disease Type, Through 2025
Table 54: Global Market for Meningococcal/Pneumococcal Vaccines, by Region, Through 2025
Table 55: Global Market for Influenza Vaccines, by Region, Through 2025
Table 56: Global Market for Pediatric Polio/Pertussis/Hib Vaccines, by Region, Through 2025
Table 57: Global Market for Rotavirus Diseases Vaccines, by Region, Through 2025
Table 58: Global Market for Endemic Diseases Vaccines, by Region, Through 2025
Table 59: Global Market for HPV Vaccines, by Region, Through 2025
Table 60: Global Market for Adult/Adolescent Booster Vaccines, by Region, Through 2025
Table 61: Global Market for Other Diseases Vaccines, by Region, Through 2025
Table 62: Seasonal Influenza Vaccines
Table 63: Vaccine, by Route of Delivery
Table 64: Site for Intramuscular Immunization, by Age
Table 65: Nasal Vaccines, by Disease
Table 66: Global Market for Animal Vaccines, by Type, Through 2025
Table 67: Global Market for Food-Producing Animals Vaccines, by Region, Through 2025
Table 68: Global Market for Companion Animals Vaccines, by Region, Through 2025
Table 69: Global Market for Other Animal Vaccines, by Region, Through 2025
Table 70: UNICEF Vaccination Price and Major Suppliers, 2020
Table 71: Estimated Life Saved due to Vaccination, 2011-2020 (Assuming No Vaccination as the Counterfactual)
Table 72: U.S. Recommended Immunization Schedule, by Vaccine Type, 2020
Table 73: Vaccine Price List, 2019
Table 74: Immunization Schedule of Canada, 2020
Table 75: Immunization Schedule of Germany, 2020
Table 76: Immunization Schedule of France, 2020
Table 77: Vaccination and Immunization Schedule of the U.K., 2020
Table 78: Immunization Schedule of Italy, 2020
Table 79: Immunization Schedule of China, 2020
Table 80: Immunization Schedule of Japan, 2020
Table 81: Immunization Schedule of India, 2020
Table 82: Number of Reported Cases in India, 2013-2016
Table 83: GAVI Support to India, 2001-2021
Table 84: Africa WHO/UNICEF Vaccination Coverage Estimate, 2014-2019
Table 85: Middle East WHO/UNICEF Vaccination Coverage Estimate, 2014-2019
Table 86: Global Market for Human Vaccines, by Region, Through 2025
Table 87: Major COVID-19 Vaccine Candidates Under Development

List of Figures
Summary Figure: Global Market for Vaccine Technologies, by Segment, 2019-2025
Figure 1: Literacy Rates in Population Above 15 Years of Age in Selected Countries, 2015
Figure 2: Infants Lacking Immunization Measles, 2018
Figure 3: Polio Cases in the U.S., 1950-2015
Figure 4: Percentage of Children Aged 19-35 Months Receiving Vaccinations in the U.S., 2019
Figure 5: Globally Immunization Coverage, 2019
Figure 6: Seasonal Flu Vaccination Coverage in the U.S., 2013-2019
Figure 7: Globally Immunization Coverage, 2013-2019
Figure 8: Diphtheria Cases in the U.S., 1945-2015
Figure 9: Seasonal Flu Vaccination Coverage in the U.S., 2013-2019
Figure 10: WHO/UNICEF Vaccine Coverage Estimate, 2018 and 2019
Figure 11: Hepatitis A Cases in the U.S., 1990-2019
Figure 12: Measles Cases in the U.S., 1960-2019
Figure 13: Chickenpox Cases in the U.S., 1975-2014
Figure 14: Global Immunization Coverage, 2019
Figure 15: Shares of Donor Contributions to GAVI Alliance, 2000-2020
Figure 16: Global Investment in R&D Vaccination, 2012-2015
Figure 17: Donation from the U.S. to GAVI Alliance, 2013-2018
Figure 18: Canada's Cash Funding to GAVI Alliance, 2014-2018
Figure 19: Germany's Funding to GAVI Alliance, 2013-2018
Figure 20: France's Funding to GAVI Alliance, 2012-2015
Figure 21: U.K.'s Funding to GAVI Alliance, 2000-2036
Figure 22: Donations from European Governments and Organizations to GAVI, 2013-2018
Figure 23: Investment by APAC Counties in Vaccination R&D, 2012-2019
Figure 24: Shares of Chinese Funding to GAVI Alliance, 2001-2021
Figure 25: Japan's Funding to GAVI Alliance, 2011-2020
Figure 26: Australia's Funding to GAVI Alliance, 2013-2017

Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Manguinhos
  • Elanco Animal Health
  • Ibio Inc.
  • Novartis Pharma Ag
  • Sanofi Pasteur

There has been increasing government interest in various parts of the world due to sudden outbreaks of major diseases such as Ebola, Zika virus, chikungunya, avian influenza, the H1N1 virus, and COVID-19; these outbreaks have been the primary reason for the recent market growth. Regulations are in place to check outbreaks due to tourists carrying the diseases, and vaccines have become a requirement in some countries and are highly recommended for international travelers. Various government programs and increased public awareness regarding viral diseases such as hepatitis, measles-mumps-rubella (MMR), and polio have augmented vaccination rates in various countries. The growth in this industry is also driven by the global population increases and the acceptance of adult vaccines.

Vaccines can significantly reduce the burden of many diseases and increase life expectancy through prevention. The introduction of newer vaccines covering many diseases is another factor pushing the market towards significant growth. New product offerings to address unmet needs, contingency planning for pandemic infections, awareness of disease prevention, improving economic conditions in developing countries, and increasing interest and investments from major pharmaceutical companies are shaping the vaccine market.

The market is mainly driven by the sales of major human vaccines such as Prevnar 13, Gardasil, ProQuad, Varivax, M-M-R II, polio/pertussis/Hib vaccines, and influenza vaccines.

Growth in the vaccine market is anticipated on the basis of technological advancements with respect to the development of novel vaccines towards emerging infectious diseases, cancers, and allergies. Continuous improvements in vaccine design, delivery technologies, and manufacturing will also help market growth.

The global animal vaccine market is also growing in importance. Increasing demand for livestock products and an increase in pet ownership are the foremost reasons for increasing vaccination in animals. Significant developments in biotechnology, informatics, and information systems have prompted better planning and execution of animal disease prevention in many countries.

In terms of geography, North America accounted for a major share in the total vaccine market, along with Asia-Pacific. The North American market is driven by strict regulations and high awareness, whereas the Asia-Pacific market is driven by high demand due to the broad prevalence of diseases such as influenza and hepatitis.

Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Astrazeneca Plc
  • Baxter International Inc.
  • Bayer Animal Health
  • Bharat Biotech International Ltd.
  • Bio-Manguinhos
  • Biological E. Ltd.
  • Bioproperties Pty Ltd.
  • Boehringer Ingelheim Gmbh
  • Bul Bio National Center Of Infectious And Parasitic Diseases Ltd. (Bb-Ncipd Ltd.)
  • Cadila Healthcare Ltd. (Zydus Cadila)
  • Ceva Sante Animale
  • China National Biotec Group (Cnbg)
  • Colorado Serum Co.
  • CSL Ltd.
  • Elanco Animal Health
  • Emergent Biosolutions Inc.
  • Fatro Spavia
  • GE Healthcare
  • Geneone Life Sciences Inc.
  • Geovax
  • Glaxosmithkline Plc
  • Green Cross Corp.
  • Ibio Inc.
  • Institut Pasteur De Dakar
  • Johnson & Johnson Inc.
  • LG Life Sciences
  • Maxcyte Inc.
  • Merck & Co., Inc.
  • Novartis Pharma Ag
  • Panacea Biotec Ltd.
  • Pfenex Inc.
  • Pfizer Inc.
  • Precigen Inc. (Formerly Intrexon)
  • Profectus Biosciences Inc.
  • PT Bio Farma
  • Replikins Ltd.
  • Sanofi Pasteur
  • Serum Institute Of India Ltd.
  • Statens Serum Institut
  • Thermo Fisher Scientific
  • Valneva Se
  • Virbac
  • Zoetis Inc.
Note: Product cover images may vary from those shown
Adroll
adroll